Avaí Bio Statistics
Total Valuation
Avaí Bio has a market cap or net worth of 25.97 million. The enterprise value is 27.76 million.
| Market Cap | 25.97M |
| Enterprise Value | 27.76M |
Important Dates
The next estimated earnings date is Wednesday, July 29, 2026.
| Earnings Date | Jul 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Avaí Bio has 153.92 million shares outstanding. The number of shares has increased by 7.67% in one year.
| Current Share Class | 153.92M |
| Shares Outstanding | 153.92M |
| Shares Change (YoY) | +7.67% |
| Shares Change (QoQ) | +0.54% |
| Owned by Insiders (%) | 12.87% |
| Owned by Institutions (%) | n/a |
| Float | 84.38M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -9.22 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.03
| Current Ratio | 0.03 |
| Quick Ratio | 0.01 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.78 |
| Interest Coverage | -5.50 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -232.02% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 52.58% |
| Weighted Average Cost of Capital (WACC) | 9.06% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -72.21% in the last 52 weeks. The beta is 0.84, so Avaí Bio's price volatility has been lower than the market average.
| Beta (5Y) | 0.84 |
| 52-Week Price Change | -72.21% |
| 50-Day Moving Average | 0.18 |
| 200-Day Moving Average | 0.34 |
| Relative Strength Index (RSI) | 50.65 |
| Average Volume (20 Days) | 134,291 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.14 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -1.48M |
| Pretax Income | -1.75M |
| Net Income | -1.75M |
| EBITDA | -1.45M |
| EBIT | -1.48M |
| Earnings Per Share (EPS) | -0.01 |
Balance Sheet
The company has 23,145 in cash and 1.79 million in debt, with a net cash position of -1.77 million or -0.01 per share.
| Cash & Cash Equivalents | 23,145 |
| Total Debt | 1.79M |
| Net Cash | -1.77M |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | -2.82M |
| Book Value Per Share | -0.02 |
| Working Capital | -3.30M |
Cash Flow
| Operating Cash Flow | -1.01M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 26,070 |
| Net Borrowing | 891,619 |
| Free Cash Flow | -1.01M |
| FCF Per Share | -0.01 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Avaí Bio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.67% |
| Shareholder Yield | -7.67% |
| Earnings Yield | -6.74% |
| FCF Yield | -3.89% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 1, 2020. It was a forward split with a ratio of 20.
| Last Split Date | Jun 1, 2020 |
| Split Type | Forward |
| Split Ratio | 20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |